Nalmefene: A Review of Its Use in the Treatment of Alcohol Dependence

Effect of Nalmefene 20 and 80 mg on the Corrected QT Interval and T-Wave Morphology

(2013) Jørgen Matz et al.   CLINICAL DRUG INVESTIGATION

1105 – Long-term efficacy of nalmefene as-needed in alcohol dependent patients with high drinking risk levels: results of a subgroup analysis

(2013) W. van den Brink et al.   EUROPEAN PSYCHIATRY

Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene

(2012) Karl Mann et al.   BIOLOGICAL PSYCHIATRY

Epidemiology and alcohol policy in Europe

(2011) Jürgen Rehm et al.   ADDICTION

Is Controlled Drinking an Acceptable Goal in the Treatment of Alcohol Dependence? A Survey of French Alcohol Specialists

(2011) A. Luquiens et al.   ALCOHOL AND ALCOHOLISM

The size and burden of mental disorders and other disorders of the brain in Europe 2010

(2011) H.U. Wittchen et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

κ-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats

(2011) Kathryn A. Nealey et al.   NEUROPHARMACOLOGY

The relation between different dimensions of alcohol consumption and burden of disease: an overview

(2010) Jürgen Rehm et al.   ADDICTION

Initial Preference for Drinking Goal in the Treatment of Alcohol Problems: II. Treatment Outcomes

(2010) S. J. Adamson et al.   ALCOHOL AND ALCOHOLISM

Initial Preference for Drinking Goal in the Treatment of Alcohol Problems: I. Baseline Differences Between Abstinence and Non-Abstinence Groups

(2010) N. Heather et al.   ALCOHOL AND ALCOHOLISM

Update on Harm-Reduction Policy and Intervention Research

(2010) G. Alan Marlatt et al.   Annual Review of Clinical Psychology

Alcohol-use disorders

(2009) Marc A Schuckit   LANCET